FindMyKOL
Clinical trialNCT00951236UnknownInterventional

Study Comparing One Versus Two Cortisone Injections for Trigger Finger

NCT00951236 is an interventional trial sponsored by Rothman Institute Orthopaedics. As of 21 Nov 2026, it has a status the registry marks as unknown. It studies One cortisone injection and Two cortisone Injections in Stenosing Tenosynovitis and Trigger Finger. The registry lists an enrollment of 392 participants at 7 sites in 1 country. The registry lists a start date of 31 May 2009.

SponsorRothman Institute OrthopaedicsEnrollment392Stenosing TenosynovitisTrigger Finger
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT00951236
FieldValue
Registry IDNCT00951236
StatusUnknown
Study typeInterventional trial
Lead sponsorRothman Institute Orthopaedics
Enrollment392
Registered sites7
Countries1
ConditionsStenosing Tenosynovitis and Trigger Finger
DrugsOne cortisone injection and Two cortisone Injections
Start31 May 2009
Last update posted12 Feb 2014

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Trigger finger, also known as stenosing tenosynovitis, is a painful condition that can cause discomfort and disability. Many physicians choose to locally inject cortisone into the infected finger although there is no current consensus as to how many injections are needed to achieve maximum relief. This study will be a prospective, randomized study to compare one versus two injections for the treatment of trigger finger.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

New Jersey, United States3 sites, 3 recruiting
  • Rothman Institute: Egg Harbor Township Location

    Egg Harbor

    Emran Sheikh, MD
    Recruiting
  • Rothman Institute: Manahawkin Location

    Manahawkin

    Emran Sheikh, MD
    Recruiting
  • Rothman Institute: Vorhees Location

    Vorhees

    Pedro Berendjiklian, MD
    Recruiting
Pennsylvania, United States4 sites, 4 recruiting
  • Rothman Institute: Media Location

    Media

    Pedro Berendjiklian, MD
    Recruiting
  • Rothman Institute Center City Location

    Philadelphia

    Charles Leinberry, MDEmran Sheikh, MDPedro Beredjiklian, MD
    Recruiting
  • Rothman Institute, Northeast Philadelphia Location

    Philadelphia

    Charles Leinberry, MD
    Recruiting
  • Rothman Institute, South Philadelphia Location

    Philadelphia

    Charles Leinberry, MD
    Recruiting

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvania: 4 sites, 4 recruitingPA4New Jersey: 3 sites, 3 recruitingNJ3ConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

One cortisone injectionTwo cortisone Injections
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Questions about NCT00951236

Each answer restates registry values shown on this page.

What is NCT00951236?

NCT00951236 is an interventional trial sponsored by Rothman Institute Orthopaedics. It studies One cortisone injection and Two cortisone Injections in Stenosing Tenosynovitis and Trigger Finger.

Who leads NCT00951236?

The registry names Charles Leinberry, MD (principal investigator, Rothman Institute), Emran Sheikh, MD (principal investigator, Rothman Institute) and Pedro Beredjiklian, MD (principal investigator, Rothman Institute) as overall officials.

Where does NCT00951236 run?

The registry lists 7 sites in 1 country. Every site with a stated country is in one country: United States.

Which drugs does NCT00951236 study?

The registered drug and biological interventions are One cortisone injection and Two cortisone Injections.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.